Basic Information
| RNALocate ID: | RLID-D:11000104 |
| RNA Symbol: | hsa-miR-320a |
| Localization: | Exosome |
RNA Information
| RNA Name: | hsa-miR-320a |
| RNA ID: | miRBase:MIMAT0000510 |
| RNA Category: | miRNA |
| Species: | Homo sapiens |
Localization Information
| Tissue/Cell Line: | Blood|B lymphoblastoid cells|Breast milk|Chronic lymphocytic leukemia cells|Colon tissue|Endothelial cells|Epithelial cells|Kidney tissue|Lymphoma tissue|Mast cells|Seminal fluid|Tongue tissue |
| Database: | EVmiRNA |
Other Subcellular Localization
| RNALocate ID | Localization | Tissue/Cell line | PubMed ID |
| RLID-D:11000391 | Microvesicle | Blood|Breast cell line|Colon cancer cell line (LIM1863)|Fibroblasts|Mesenchymal stem cells|Urine |
ncRNA Disease Information
| Resource | RNA Symbol | Disease | Link |
| MNDR | hsa-miR-320a | Multiple sclerosis chronic progressive | MNDR-E-MI-39144 |
| MNDR | hsa-mir-320a | Medulloblastoma | MNDR-E-MI-39145 |
| MNDR | hsa-miR-320a | Uterine corpus endometrial carcinoma | MNDR-E-MI-39146 |
| MNDR | hsa-miR-320a | Autism spectrum disorder | MNDR-E-MI-39147 |
| MNDR | hsa-miR-320a | Lymphoma | MNDR-E-MI-39148 |
| MNDR | hsa-miR-320a | Lymphoma non-hodgkin | MNDR-E-MI-39149 |
| MNDR | hsa-mir-320a | Non-hodgkin lymphoma somatic | MNDR-E-MI-39150 |
| MNDR | hsa-miR-320a | Estrogen-receptor positive breast cancer | MNDR-E-MI-39151 |
| MNDR | hsa-miR-320a | Estrogen-receptor negative breast cancer | MNDR-E-MI-39152 |
| MNDR | hsa-miR-320a | Progesterone-receptor positive breast cancer | MNDR-E-MI-39153 |
| MNDR | hsa-miR-320a | Progesterone-receptor negative breast cancer | MNDR-E-MI-39154 |
| MNDR | hsa-miR-320a | Her2-receptor positive breast cancer | MNDR-E-MI-39155 |
| MNDR | hsa-miR-320a | Precursor cell lymphoblastic leukemia-lymphoma | MNDR-E-MI-39156 |
| MNDR | hsa-mir-320a | Colorectal carcinoma | MNDR-E-MI-39157 |
| MNDR | hsa-mir-320a | Melanoma and neural system tumor syndrome | MNDR-E-MI-39158 |
| MNDR | hsa-mir-320a | Acth-independent macronodular adrenal hyperplasia; aimah | MNDR-E-MI-39159 |
| MNDR | hsa-mir-320a | Prostate cancer | MNDR-E-MI-39160 |
| MNDR | hsa-miR-320a | Prostate cancer | MNDR-E-MI-39161 |
| MNDR | hsa-mir-320a | Chronic lymphocytic leukemia | MNDR-E-MI-39162 |
| MNDR | hsa-mir-320a | Gastric cancer | MNDR-E-MI-39163 |
| MNDR | hsa-miR-320a | Gastric cancer | MNDR-E-MI-39164 |
| MNDR | hsa-mir-320a | Alzheimer disease | MNDR-E-MI-39165 |
| MNDR | hsa-miR-320a | Alzheimer disease | MNDR-E-MI-39166 |
| MNDR | hsa-mir-320a | Sickle cell diseases | MNDR-E-MI-39167 |
| MNDR | hsa-miR-320a | Intracranial aneurysm | MNDR-E-MI-39168 |
| MNDR | hsa-miR-320a | Bladder cancer | MNDR-E-MI-39169 |
| MNDR | hsa-miR-320a | Dysautonomia familial | MNDR-E-MI-39170 |
| MNDR | hsa-miR-320a | Leukemia | MNDR-E-MI-39171 |
| MNDR | hsa-mir-320a | Leiomyoma | MNDR-E-MI-39172 |
| MNDR | hsa-mir-320a | Autism susceptibility to | MNDR-E-MI-39173 |
| MNDR | hsa-miR-320a | Huntington disease | MNDR-E-MI-39174 |
| MNDR | hsa-miR-320a | Cardiovascular disease | MNDR-E-MI-39175 |
| MNDR | hsa-mir-320a | Cardiomyopathy dilated | MNDR-E-MI-39176 |
| MNDR | hsa-miR-320a | Carotid stenosis | MNDR-E-MI-39177 |
| MNDR | hsa-mir-320a | Lung cancer | MNDR-E-MI-39178 |
| MNDR | hsa-miR-320a | Lung cancer | MNDR-E-MI-39179 |
| MNDR | hsa-mir-320a | Osteopetrosis | MNDR-E-MI-39180 |
| MNDR | hsa-mir-320a | Interstitial cystitis | MNDR-E-MI-39181 |
| MNDR | hsa-miR-320a | Fragile x syndrome | MNDR-E-MI-39182 |
| MNDR | hsa-mir-320a | Parkinson disease | MNDR-E-MI-39183 |
| MNDR | hsa-miR-320a | Parkinson disease | MNDR-E-MI-39184 |
| MNDR | hsa-mir-320a | Breast cancer | MNDR-E-MI-39185 |
| MNDR | hsa-miR-320a | Breast cancer | MNDR-E-MI-39186 |
| MNDR | hsa-mir-320a | Cancer | MNDR-E-MI-39187 |
| MNDR | hsa-mir-320a | Pancreatic cancer | MNDR-E-MI-39188 |
| MNDR | hsa-miR-320a | Pancreatic cancer | MNDR-E-MI-39189 |
| MNDR | hsa-mir-320a | Melanoma | MNDR-E-MI-39190 |
| MNDR | hsa-mir-320a | Supravalvar aortic stenosis | MNDR-E-MI-39191 |
| MNDR | hsa-miR-320a | Atherosclerosis | MNDR-E-MI-39192 |
| MNDR | hsa-mir-320a | Leiomyosarcoma | MNDR-E-MI-39193 |
| MNDR | hsa-miR-320a | Nephroblastoma | MNDR-E-MI-39194 |
| MNDR | hsa-mir-320a | Colon cancer | MNDR-E-MI-39195 |
| MNDR | hsa-miR-320a | Colon cancer | MNDR-E-MI-39196 |
| MNDR | hsa-miR-320a | Ischemic attack transient | MNDR-E-MI-39197 |
| MNDR | hsa-miR-320a | Colon adenocarcinoma | MNDR-E-MI-39198 |
| MNDR | hsa-miR-320a | Multiple sclerosis | MNDR-E-MI-39199 |
| MNDR | hsa-miR-320a | Multiple sclerosis relapsing-remitting | MNDR-E-MI-39200 |
| MNDR | hsa-mir-320a | Multiple sclerosis relapsing-remitting | MNDR-E-MI-39201 |
| MNDR | hsa-mir-320a | Ovarian cancer | MNDR-E-MI-39202 |
| MNDR | hsa-miR-320a | Ovarian cancer | MNDR-E-MI-39203 |
| MNDR | hsa-miR-320a | Prostate adenocarcinoma | MNDR-E-MI-39204 |
| MNDR | hsa-miR-320a | Kidney cancer | MNDR-E-MI-39205 |
| MNDR | hsa-miR-320a | Carcinoma ductal breast | MNDR-E-MI-39206 |
| MNDR | hsa-miR-320a | Glioblastoma | MNDR-E-MI-39207 |
| MNDR | hsa-mir-320a | Glioblastoma | MNDR-E-MI-39208 |
| MNDR | hsa-miR-320a | Glioma | MNDR-E-MI-39209 |
| MNDR | hsa-mir-320a | Glioma | MNDR-E-MI-39210 |
| MNDR | hsa-miR-320a | Chronic obstructive pulmonary disease | MNDR-E-MI-39211 |
| MNDR | hsa-mir-320a | Ischemia | MNDR-E-MI-39212 |
| MNDR | hsa-miR-320a | Amyotrophic lateral sclerosis | MNDR-E-MI-39213 |
| MNDR | hsa-mir-320a | Osteosarcoma | MNDR-E-MI-39214 |
| MNDR | hsa-miR-320a | Osteosarcoma | MNDR-E-MI-39215 |
| MNDR | hsa-miR-320a | Turner syndrome | MNDR-E-MI-39216 |
| MNDR | hsa-miR-320a | Uterine cancer | MNDR-E-MI-39217 |
| MNDR | hsa-miR-320a | Gastric adenocarcinoma | MNDR-E-MI-39218 |
| MNDR | hsa-miR-320a | Cervical squamous cell carcinoma | MNDR-E-MI-39219 |
| MNDR | hsa-miR-320a | Lung squamous cell carcinoma | MNDR-E-MI-39220 |
| MNDR | hsa-mir-320a | Carcinoma lung non-small-cell | MNDR-E-MI-39221 |
| MNDR | hsa-miR-320a | Lung adenocarcinoma | MNDR-E-MI-39222 |
| MNDR | hsa-miR-320a | Thyroid carcinoma | MNDR-E-MI-39223 |
| MNDR | hsa-miR-320a | Bladder urothelial carcinoma | MNDR-E-MI-39224 |
| MNDR | hsa-mir-320a | Myasthenia gravis | MNDR-E-MI-39225 |
| MNDR | hsa-miR-320a | Myasthenia gravis autoimmune experimental | MNDR-E-MI-39226 |
| MNDR | hsa-miR-320a | Kidney renal clear cell carcinoma | MNDR-E-MI-39227 |
| MNDR | hsa-mir-320a | Renal cell carcinoma | MNDR-E-MI-39228 |
| MNDR | hsa-miR-320a | Intrahepatic cholangiocarcinoma | MNDR-E-MI-39229 |
| MNDR | hsa-miR-320a | Cholangiocarcinoma | MNDR-E-MI-39230 |
| MNDR | hsa-miR-320a | Esophageal cancer | MNDR-E-MI-39231 |
| MNDR | hsa-miR-320a | Liver cirrhosis | MNDR-E-MI-39232 |
| MNDR | hsa-miR-320a | Head and neck squamous cell carcinoma | MNDR-E-MI-39233 |
| MNDR | hsa-mir-320a | Squamous cell carcinoma head and neck | MNDR-E-MI-39234 |
| MNDR | hsa-mir-320a | Heart failure | MNDR-E-MI-39235 |
| MNDR | hsa-miR-320a | Fibromyalgia | MNDR-E-MI-39236 |
| MNDR | hsa-mir-320a | Fibromyalgia | MNDR-E-MI-39237 |
| MNDR | hsa-miR-320a | Adenoma | MNDR-E-MI-39238 |
| MNDR | hsa-miR-320a | Breast invasive carcinoma | MNDR-E-MI-39239 |
| MNDR | hsa-miR-320a | Early hepatocellular carcinoma | MNDR-E-MI-39240 |
| MNDR | hsa-mir-320a | Hepatocellular carcinoma | MNDR-E-MI-39241 |
| MNDR | hsa-miR-320a | B-cell lymphoma | MNDR-E-MI-39242 |
| MNDR | hsa-miR-320a | Rheumatoid arthritis | MNDR-E-MI-39243 |
| MNDR | hsa-mir-320a | Muscle atrophy | MNDR-E-MI-39244 |
| MNDR | hsa-mir-320a | Childhood leukemia | MNDR-E-MI-39245 |
| MNDR | hsa-miR-320a | Barrett's adenocarcinoma | MNDR-E-MI-39246 |
| MNDR | hsa-miR-320a | Hodgkin disease | MNDR-E-MI-39247 |
| MNDR | hsa-miR-320a | Burkitt lymphoma | MNDR-E-MI-39248 |
| MNDR | hsa-miR-320a | Neuromyelitis optica | MNDR-E-MI-39249 |
| MNDR | hsa-mir-320a | Systemic lupus erythematosus | MNDR-E-MI-39250 |
| MNDR | hsa-miR-320a | Acute myelocytic leukemia | MNDR-E-MI-39251 |
| MNDR | hsa-mir-320a | Leukemia acute myeloid | MNDR-E-MI-39252 |
| MNDR | hsa-mir-320a | Gastrointestinal stromal tumor | MNDR-E-MI-39253 |
| MNDR | hsa-mir-320a | Colorectal cancer | MNDR-E-MI-39254 |
| MNDR | hsa-miR-320a | Colorectal cancer | MNDR-E-MI-39255 |
| MNDR | hsa-mir-320a | Nasopharyngeal carcinoma | MNDR-E-MI-39256 |
| MNDR | hsa-mir-320a | Nasopharynx carcinoma | MNDR-E-MI-39257 |
| MNDR | hsa-mir-320a | Diabetes mellitus | MNDR-E-MI-39258 |
| MNDR | hsa-mir-320a | Diabetes mellitus type 2 | MNDR-E-MI-39259 |
| MNDR | hsa-miR-320a | Multiple myeloma | MNDR-E-MI-39260 |
| MNDR | hsa-mir-320a | St elevation myocardial infarction | MNDR-E-MI-39261 |
| MNDR | hsa-mir-320a | Bladder neoplasms | MNDR-E-MI-39262 |
| MNDR | hsa-mir-320a | Cardiovascular | MNDR-E-MI-39263 |
| MNDR | hsa-miR-320a | Ependymoma | MNDR-E-MI-39264 |
| MNDR | hsa-mir-320a | Prostatic neoplasms | MNDR-E-MI-39265 |
| MNDR | hsa-miR-320a | Prostatic neoplasms | MNDR-E-MI-39266 |
| MNDR | hsa-miR-320a | Cerebral hemorrhage traumatic | MNDR-E-MI-39267 |
| MNDR | hsa-mir-320a | Muscular disorders atrophic | MNDR-E-MI-39268 |
| MNDR | hsa-miR-320a | Venous thromboembolism | MNDR-E-MI-39269 |
| MNDR | hsa-miR-320a | Stroke lacunar | MNDR-E-MI-39270 |
| MNDR | hsa-mir-320a | Cardiotoxicity | MNDR-E-MI-39271 |
| MNDR | hsa-miR-320a | Breast cancer her3+ negative | MNDR-E-MI-39272 |
| MNDR | hsa-miR-320a | High grade dysplastic nodule | MNDR-E-MI-39273 |
| MNDR | hsa-mir-320a | Leukemia chronic lymphatic susceptibility | MNDR-E-MI-39274 |
| MNDR | hsa-mir-320a | Low grade dysplastic nodule | MNDR-E-MI-39275 |
| MNDR | hsa-miR-320a | Solid-pseudopapillary neoplasm of pancreas | MNDR-E-MI-39276 |
| MNDR | hsa-mir-320a | Stroke susceptibility | MNDR-E-MI-39277 |
| MNDR | hsa-miR-320a | Tubulovillous adenoma | MNDR-E-MI-39278 |
RNA Interaction Information
| Resource | RNA Symbol | Species | Link | RNALocate ID |
| RNAInter | ABCG2 | Homo sapiens | RR00024747 |
TOP